Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
about
Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE.Retrospective analysis of tigecycline shows that it may be an option for children with severe infections.Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials.Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis.Combination therapy for extensively-drug resistant gram-negative bacteria.Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
P2860
Q33649288-89CCDC53-76A5-4FAE-B686-49C50D2571D7Q36228369-C2E670A3-C903-4FEF-894A-EF81AAF17064Q37511815-5C17DA23-10F4-4EB0-9D7C-ADF3B3A7887EQ39038590-E3905542-D0A2-451A-B64D-7D72316E7A4BQ40083827-5B48F6B2-8D94-4C77-AEFA-F112AADBA714Q40624454-D5653514-1264-43B3-A36E-75C00DBC5FA7Q47129511-1D5D9692-CD67-46CB-B0CD-6A092849CD57Q47143645-5356E333-D182-45EB-A2A4-CE632FEBF11BQ47819621-9123057C-FC3B-45AF-A75E-A250D003473AQ50082670-C140968B-64EB-4A10-80B2-DCDAF98E28B7
P2860
Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@ast
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@en
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@nl
type
label
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@ast
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@en
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@nl
prefLabel
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@ast
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@en
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@nl
P2093
P2860
P921
P1433
P1476
Comparable Efficacy of Tigecyc ...... nia in Critically Ill Patients
@en
P2093
Chae-Man Lim
Jae-Young Moon
Jin Won Huh
Sang-Bum Hong
Sang-Ho Choi
Yong Pil Chong
Younsuck Koh
P2860
P304
P356
10.1371/JOURNAL.PONE.0150642
P407
P577
2016-01-01T00:00:00Z